Elevation Wealth Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$143K Buy
339
+24
+8% +$9.6K 0.04% 172
2026
Q2
$114K Buy
315
+39
+14% +$13.4K 0.03% 180
2026
Q1
$97.1K Sell
276
-26
-9% -$9.27K 0.03% 170
2025
Q4
$98.8K Buy
302
+40
+15% +$12.7K 0.04% 171
2025
Q3
$73.9K Buy
262
+30
+13% +$8.7K 0.03% 201
2025
Q2
$64.8K Hold
232
– – 0.03% 208
2025
Q1
$72.3K Hold
232
– – 0.03% 195
2024
Q4
$60.5K Buy
232
+26
+13% +$7.71K 0.03% 209
2024
Q3
$66.4K Hold
206
– – 0.03% 196
2024
Q2
$64.4K Hold
206
– – 0.03% 194
2024
Q1
$58.6K Hold
206
– – 0.03% 204
2023
Q4
$55.4K Hold
206
– – 0.03% 197
2023
Q3
$55.4K Hold
206
– – 0.05% 140
2023
Q2
$45.7K Hold
206
– – 0.04% 162
2023
Q1
$49.8K Buy
+206
New +$50.6K 0.05% 155

Other funds holding AMGN

Elevation Wealth Partners's AMGN Position: Q3 2026 in Review

Elevation Wealth Partners increased its Amgen (AMGN) stake by 7.6% in Q3 2026, buying an estimated $9.6K and bringing the position to 339 shares worth $143K. The position accounts for 0.04% of the portfolio, ranked #172.

Elevation Wealth Partners first reported a position in AMGN in Q1 2023 and has held it in 15 quarters since. 1,338 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Elevation Wealth Partners held 339 shares of Amgen worth $143K as of Q3 2026.
  • Elevation Wealth Partners bought 24 Amgen shares in Q3 2026, an estimated $9.6K.
  • Amgen made up 0.04% of Elevation Wealth Partners's portfolio in Q3 2026, its #172 holding.
  • Elevation Wealth Partners first reported a position in Amgen in Q1 2023 and has held it in 15 quarters since.
  • 1,338 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Elevation Wealth Partners's 13F filing for Q3 2026, filed 7 Oct 2026.